129 related articles for article (PubMed ID: 34850045)
1. Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.
Chkheidze R; Raisanen J; Gagan J; Richardson TE; Pinho MC; Raj K; Achilleos M; Slepicka C; White CL; Evers BM; Patel TR; Malter JS; Hatanpaa KJ
J Neuropathol Exp Neurol; 2021 Dec; 80(12):1092-1098. PubMed ID: 34850045
[TBL] [Abstract][Full Text] [Related]
2. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1.
Suwala AK; Stichel D; Schrimpf D; Maas SLN; Sill M; Dohmen H; Banan R; Reinhardt A; Sievers P; Hinz F; Blattner-Johnson M; Hartmann C; Schweizer L; Boldt HB; Kristensen BW; Schittenhelm J; Wood MD; Chotard G; Bjergvig R; Das A; Tabori U; Hasselblatt M; Korshunov A; Abdullaev Z; Quezado M; Aldape K; Harter PN; Snuderl M; Hench J; Frank S; Acker T; Brandner S; Winkler F; Wesseling P; Pfister SM; Reuss DE; Wick W; von Deimling A; Jones DTW; Sahm F
Acta Neuropathol; 2021 Jul; 142(1):179-189. PubMed ID: 33876327
[TBL] [Abstract][Full Text] [Related]
3. IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation.
Barresi V; Simbolo M; Mafficini A; Martini M; Calicchia M; Piredda ML; Ciaparrone C; Bonizzato G; Ammendola S; Caffo M; Pinna G; Sala F; Lawlor RT; Ghimenton C; Scarpa A
Acta Neuropathol Commun; 2021 Dec; 9(1):200. PubMed ID: 34952640
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification of a complex structural rearrangement of the RB1 locus in an infant with sporadic, isolated, intracranial, sellar region retinoblastoma.
Schieffer KM; Feldman AZ; Kautto EA; McGrath S; Miller AR; Hernandez-Gonzalez ME; LaHaye S; Miller KE; Koboldt DC; Brennan P; Kelly B; Wetzel A; Agarwal V; Shatara M; Conley S; Rodriguez DP; Abu-Arja R; Shaikhkhalil A; Snuderl M; Orr BA; Finlay JL; Osorio DS; Drapeau AI; Leonard JR; Pierson CR; White P; Magrini V; Mardis ER; Wilson RK; Cottrell CE; Boué DR
Acta Neuropathol Commun; 2021 Apr; 9(1):61. PubMed ID: 33827698
[TBL] [Abstract][Full Text] [Related]
5. Spectrum of germline
Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
[TBL] [Abstract][Full Text] [Related]
6. Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.
Goldhoff P; Clarke J; Smirnov I; Berger MS; Prados MD; James CD; Perry A; Phillips JJ
J Neuropathol Exp Neurol; 2012 Jan; 71(1):83-9. PubMed ID: 22157621
[TBL] [Abstract][Full Text] [Related]
7. RB1‑promoter methylation in glioblastoma: A rare event in glioblastoma.
Urbschat S; Breitfelder G; Henia M; Schulz-Schaeffer W; Sippl C; Oertel J; Ketter R
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37264960
[TBL] [Abstract][Full Text] [Related]
8. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features.
Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE
Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
10. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Manzano RG; Catalan-Latorre A; Brugarolas A
BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous identification of clinically relevant
Xu L; Shen L; Polski A; Prabakar RK; Shah R; Jubran R; Kim JW; Biegel J; Kuhn P; Cobrinik D; Hicks J; Gai X; Berry JL
Ophthalmic Genet; 2020 Dec; 41(6):526-532. PubMed ID: 32799607
[TBL] [Abstract][Full Text] [Related]
12. Impact of RB1 gene mutation type in retinoblastoma patients on clinical presentation and management outcome.
Mehyar M; Mosallam M; Tbakhi A; Saab A; Sultan I; Deebajah R; Jaradat I; AlJabari R; Mohammad M; AlNawaiseh I; Al-Hussaini M; Yousef YA
Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):152-159. PubMed ID: 32222358
[TBL] [Abstract][Full Text] [Related]
13. Next-generation whole exome sequencing of glioblastoma with a primitive neuronal component.
Xu G; Zheng H; Li JY
Brain Tumor Pathol; 2019 Jul; 36(3):129-134. PubMed ID: 30715630
[TBL] [Abstract][Full Text] [Related]
14. Genetic and expression variations of cell cycle pathway genes in brain tumor patients.
Naqvi AZ; Mahjabeen I; Ameen S; Ahmed MW; Khan AU; Akram Z; Kayani MA
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32373934
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the RB1 gene and the inheritance patterns of retinoblastoma in Jordan.
Yousef YA; Tbakhi A; Al-Hussaini M; AlNawaiseh I; Saab A; Afifi A; Naji M; Mohammad M; Deebajah R; Jaradat I; Sultan I; Mehyar M
Fam Cancer; 2018 Apr; 17(2):261-268. PubMed ID: 28803391
[TBL] [Abstract][Full Text] [Related]
16. Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes.
Offin M; Chan JM; Tenet M; Rizvi HA; Shen R; Riely GJ; Rekhtman N; Daneshbod Y; Quintanal-Villalonga A; Penson A; Hellmann MD; Arcila ME; Ladanyi M; Pe'er D; Kris MG; Rudin CM; Yu HA
J Thorac Oncol; 2019 Oct; 14(10):1784-1793. PubMed ID: 31228622
[TBL] [Abstract][Full Text] [Related]
17. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma.
Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM
Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525
[TBL] [Abstract][Full Text] [Related]
18. Molecular alterations in retinoblastoma beyond RB1.
Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
[TBL] [Abstract][Full Text] [Related]
19. Dysplastic Lipoma: A Distinctive Atypical Lipomatous Neoplasm With Anisocytosis, Focal Nuclear Atypia, p53 Overexpression, and a Lack of MDM2 Gene Amplification by FISH; A Report of 66 Cases Demonstrating Occasional Multifocality and a Rare Association With Retinoblastoma.
Michal M; Agaimy A; Contreras AL; Svajdler M; Kazakov DV; Steiner P; Grossmann P; Martinek P; Hadravsky L; Michalova K; Svajdler P; Szep Z; Michal M; Fetsch JF
Am J Surg Pathol; 2018 Nov; 42(11):1530-1540. PubMed ID: 30001242
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological induction of translational readthrough of nonsense mutations in the retinoblastoma (RB1) gene.
Palomar-Siles M; Yurevych V; Bykov VJN; Wiman KG
PLoS One; 2023; 18(11):e0292468. PubMed ID: 37917619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]